Products
News
Resources
Contact
Language
简体中文
繁體中文
English
日本語
한국어
Tiếng Việt
Overview
Latest
Regional
Industry
Featured
Multimedia
Other Languages
Public Company News
All
APAC
Global
All
APAC
Global
All
APAC
Global
All
APAC
Global
{{toptitleLeft}}
{{toptitleRight}}
{{selectTitle}}
{{toptitleLeft}}
{{index}}
{{select_list_per.name}}
Time
{{showName}}
{{weixin_name}}
X
{{listname}}
Loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.headline}}
{{storydata.create_time}}
{{storydata.headline}}
{{storydata.create_time}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
loading
The End
Network Errors Please Retry
Poster Highlighting Clinical Data of KN046 Plus Nab-Paclitaxel/Gemcitabine as First-Line Treatment for Pancreatic Cancer Is Presented at ASCO 2021
2021-06-07 09:53
CSOP Asset Management Ltd. Chooses SS&C to Support Operations
2021-06-07 09:00
Ascletis Received China IND Approval of Its FXR Agonist ASC42 for Chronic Hepatitis B Indication
2021-06-07 08:30
Innovent Releases Phase 1 Results of Pemigatinib in Chinese Patients with Advanced Solid Tumors at ASCO Annual Meeting 2021
2021-06-07 08:00
Innovent Releases the Phase Ia/Ib Dose-Escalation Trial Results of IBI110 (anti-LAG-3) in Patients with Advanced Solid Tumors at ASCO Annual Meeting 2021
2021-06-07 08:00
Innovent and AnHeart Release Preliminary Results from the Phase II TRUST Trial of Taletrectinib in ROS1 Fusion Positive NSCLC at the ASCO 2021 Annual Meeting
2021-06-07 08:00
Innovent and HUTCHMED Release Phase 1b preliminary Results of TYVYT (Sintilimab Injection) plus Fruquintinib as a Third Line Treatment for Advanced Colorectal Cancer at ASCO Annual Meeting 2021
2021-06-07 08:00
ANVIL by SK Telecom and Action Square will participate in the world's largest game exhibition, E3 2021
2021-06-05 21:00
Meituan Launches Green Tech Fund, and Other Initiatives on World Environment Day
2021-06-05 07:00
Ucommune International Ltd. Announces Unaudited First Quarter 2021 Financial Results
2021-06-05 04:30
Mercurity Fintech Holding Inc. Reports First Quarter 2021 Financial Results
2021-06-05 04:05
Dogness Reports First Half Fiscal Year 2021 Financial Results
2021-06-04 20:15
AGBA Acquisition Limited Receives Expected Notice From Nasdaq Regarding Delayed Quarterly Report
2021-06-04 20:00
Hwaseung Corporation to Play Key Roles after Completing Restructuring
2021-06-04 19:00
Gaotu Techedu Inc. Announces Effectiveness of Name Change
2021-06-04 18:56
Farmmi Receives NASDAQ Notification Regarding Minimum Bid Requirements
2021-06-04 18:00
Goldpac Financial Security Chip Operating System Accelerating the Replacement by Domestic One
2021-06-04 17:15
Cheetah Mobile to Report First Quarter 2021 Financial Results on June 11th, 2021
2021-06-04 17:12
GWM's Building of Hydrogen Industry Ecology Boosts New Energy Revolution
2021-06-04 14:54
Sihuan Pharmaceutical (0460.HK) Obtained the Exclusive Distribution Right for LipiVage(R) Fat Collection System in Greater China and South Korea
2021-06-04 14:03
1
1506
1507
1508
1509
1510
3741